ERBB2 and breast cancer: Notably, by assuming a recessive genetic model, this variant was associated with a markedly higher risk for the triple-negative subtype of breast cancer (OR = 18.65, 95% CI 5.42-64.13, P < 0.0001; Table 2) but not for the luminal-like or HER2+ subtypes.